Association between vaginal microbiota and vaginal inflammatory immune markers in postmenopausal women.

IF 2.8 3区 医学 Q1 OBSTETRICS & GYNECOLOGY
Elizabeth H Byrne, Hoseung Song, Sujatha Srinivasan, David N Fredricks, Susan D Reed, Katherine A Guthrie, Michael Wu, Caroline M Mitchell
{"title":"Association between vaginal microbiota and vaginal inflammatory immune markers in postmenopausal women.","authors":"Elizabeth H Byrne, Hoseung Song, Sujatha Srinivasan, David N Fredricks, Susan D Reed, Katherine A Guthrie, Michael Wu, Caroline M Mitchell","doi":"10.1097/GME.0000000000002362","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>In premenopausal individuals, vaginal microbiota diversity and lack of Lactobacillus dominance are associated with greater mucosal inflammation, which is linked to a higher risk of cervical dysplasia and infections. It is not known if the association between the vaginal microbiota and inflammation is present after menopause, when the vaginal microbiota is generally higher-diversity and fewer people have Lactobacillus dominance.</p><p><strong>Methods: </strong>This is a post hoc analysis of a subset of postmenopausal individuals enrolled in a randomized trial for treatment of moderate-severe vulvovaginal discomfort that compared vaginal moisturizer, estradiol, or placebo. Vaginal fluid samples from 0, 4, and 12 weeks were characterized using 16S rRNA gene sequencing (microbiota) and MesoScale Discovery (vaginal fluid immune markers: IL-1b, IL-1a, IL-2, IL-6, IL-18, IL-10, IL-9, IL-13, IL-8, IP10, MIP1a, MIP1b, MIP3a). Global associations between cytokines and microbiota (assessed by relative abundance of individual taxa and Shannon index for alpha, or community, diversity) were explored, adjusting for treatment arm, using linear mixed models, principal component analysis, and Generalized Linear Mixed Model + Microbiome Regression-based Kernel Association Test (GLMM-MiRKAT).</p><p><strong>Results: </strong>A total of 119 individuals with mean age of 61 years were included. At baseline, 29.5% of participants had a Lactobacillus -dominant vaginal microbiota. Across all timepoints, alpha diversity (Shannon index, P = 0.003) was highly associated with immune markers. Individual markers that were associated with Lactobacillus dominance were similar to those observed in premenopausal people: IL-10, IL-1b, IL-6, IL-8 (false discovery rate [FDR] < 0.01), IL-13 (FDR = 0.02), and IL-2 (FDR = 0.09). Over 12 weeks, change in alpha diversity was associated with change in cytokine concentration (Shannon, P = 0.018), with decreased proinflammatory cytokine concentrations observed with decreasing alpha diversity.</p><p><strong>Conclusions: </strong>In this cohort of postmenopausal individuals, Lactobacillus dominance and lower alpha diversity were associated with lower concentrations of inflammatory immune markers, as has been reported in premenopausal people. This suggests that after menopause lactobacilli continue to have beneficial effects on vaginal immune homeostasis, despite lower prevalence.</p>","PeriodicalId":18435,"journal":{"name":"Menopause: The Journal of The North American Menopause Society","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11213660/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Menopause: The Journal of The North American Menopause Society","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/GME.0000000000002362","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: In premenopausal individuals, vaginal microbiota diversity and lack of Lactobacillus dominance are associated with greater mucosal inflammation, which is linked to a higher risk of cervical dysplasia and infections. It is not known if the association between the vaginal microbiota and inflammation is present after menopause, when the vaginal microbiota is generally higher-diversity and fewer people have Lactobacillus dominance.

Methods: This is a post hoc analysis of a subset of postmenopausal individuals enrolled in a randomized trial for treatment of moderate-severe vulvovaginal discomfort that compared vaginal moisturizer, estradiol, or placebo. Vaginal fluid samples from 0, 4, and 12 weeks were characterized using 16S rRNA gene sequencing (microbiota) and MesoScale Discovery (vaginal fluid immune markers: IL-1b, IL-1a, IL-2, IL-6, IL-18, IL-10, IL-9, IL-13, IL-8, IP10, MIP1a, MIP1b, MIP3a). Global associations between cytokines and microbiota (assessed by relative abundance of individual taxa and Shannon index for alpha, or community, diversity) were explored, adjusting for treatment arm, using linear mixed models, principal component analysis, and Generalized Linear Mixed Model + Microbiome Regression-based Kernel Association Test (GLMM-MiRKAT).

Results: A total of 119 individuals with mean age of 61 years were included. At baseline, 29.5% of participants had a Lactobacillus -dominant vaginal microbiota. Across all timepoints, alpha diversity (Shannon index, P = 0.003) was highly associated with immune markers. Individual markers that were associated with Lactobacillus dominance were similar to those observed in premenopausal people: IL-10, IL-1b, IL-6, IL-8 (false discovery rate [FDR] < 0.01), IL-13 (FDR = 0.02), and IL-2 (FDR = 0.09). Over 12 weeks, change in alpha diversity was associated with change in cytokine concentration (Shannon, P = 0.018), with decreased proinflammatory cytokine concentrations observed with decreasing alpha diversity.

Conclusions: In this cohort of postmenopausal individuals, Lactobacillus dominance and lower alpha diversity were associated with lower concentrations of inflammatory immune markers, as has been reported in premenopausal people. This suggests that after menopause lactobacilli continue to have beneficial effects on vaginal immune homeostasis, despite lower prevalence.

绝经后妇女阴道微生物群与阴道炎症免疫标记物之间的关系。
目的:在绝经前的人群中,阴道微生物群的多样性和乳酸杆菌优势的缺乏与粘膜炎症的加重有关,而粘膜炎症与宫颈发育不良和感染的高风险有关。目前还不清楚绝经后阴道微生物群与炎症之间是否存在关联,因为绝经后阴道微生物群的多样性通常较高,乳酸杆菌占优势的人较少:这是对参加治疗中度-重度外阴阴道不适随机试验的绝经后人群进行的事后分析,该试验比较了阴道保湿剂、雌二醇或安慰剂。使用 16S rRNA 基因测序(微生物群)和 MesoScale Discovery(阴道液免疫标记物)对 0、4 和 12 周的阴道液样本进行了表征:IL-1b、IL-1a、IL-2、IL-6、IL-18、IL-10、IL-9、IL-13、IL-8、IP10、MIP1a、MIP1b、MIP3a)。利用线性混合模型、主成分分析和广义线性混合模型+基于微生物组回归的核关联检验(GLMM-MiRKAT),探讨了细胞因子与微生物群(通过单个分类群的相对丰度和α或群落多样性的香农指数评估)之间的整体关联,并对治疗组进行了调整:共纳入 119 人,平均年龄 61 岁。基线时,29.5%的参与者的阴道微生物群以乳酸杆菌为主。在所有时间点上,α多样性(香农指数,P = 0.003)与免疫标记物高度相关。与乳酸杆菌优势相关的单个标记物与绝经前人群中观察到的标记物相似:IL-10、IL-1b、IL-6、IL-8(假发现率 [FDR] < 0.01)、IL-13(FDR = 0.02)和 IL-2(FDR = 0.09)。12周内,α多样性的变化与细胞因子浓度的变化相关(Shannon,P = 0.018),随着α多样性的降低,促炎细胞因子浓度也随之降低:在这组绝经后人群中,乳酸杆菌优势和较低的α多样性与较低的炎症性免疫标志物浓度有关,这与绝经前人群中的报道相同。这表明,在绝经后,尽管乳酸杆菌的流行率较低,但乳酸杆菌仍能对阴道免疫平衡产生有益的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.40
自引率
7.40%
发文量
330
审稿时长
3-8 weeks
期刊介绍: ​Menopause, published monthly, provides a forum for new research, applied basic science, and clinical guidelines on all aspects of menopause. The scope and usefulness of the journal extend beyond gynecology, encompassing many varied biomedical areas, including internal medicine, family practice, medical subspecialties such as cardiology and geriatrics, epidemiology, pathology, sociology, psychology, anthropology, and pharmacology. This forum is essential to help integrate these areas, highlight needs for future research, and enhance health care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信